Secondary |
Product Used For Unknown Indication |
30.3% |
Depression |
11.1% |
Insomnia |
9.6% |
Schizophrenia |
9.6% |
Delusional Disorder, Unspecified Type |
8.2% |
Psychotic Disorder |
8.2% |
Pain |
2.9% |
Dermatomyositis |
2.4% |
Drug Use For Unknown Indication |
2.4% |
Prostate Cancer |
2.4% |
Diabetes Mellitus |
1.9% |
Anxiety |
1.4% |
Atrial Fibrillation |
1.4% |
Back Pain |
1.4% |
Sleep Disorder |
1.4% |
Thrombophilia |
1.4% |
Abortion Induced |
1.0% |
Back Injury |
1.0% |
Rash |
1.0% |
Tachyarrhythmia |
1.0% |
|
Hypoglycaemia |
9.1% |
Renal Failure Acute |
9.1% |
Contusion |
4.5% |
Drug Administration Error |
4.5% |
Drug Interaction |
4.5% |
Dry Mouth |
4.5% |
Epistaxis |
4.5% |
Gastric Haemorrhage |
4.5% |
Lower Gastrointestinal Haemorrhage |
4.5% |
Medication Error |
4.5% |
Myocardial Infarction |
4.5% |
Nervousness |
4.5% |
Oligohydramnios |
4.5% |
Pain In Extremity |
4.5% |
Pruritus |
4.5% |
Pyelonephritis |
4.5% |
Rheumatoid Arthritis |
4.5% |
Somnolence |
4.5% |
Urticaria |
4.5% |
Vaginal Haemorrhage |
4.5% |
|
Concomitant |
Product Used For Unknown Indication |
54.9% |
Drug Use For Unknown Indication |
7.6% |
Crohn's Disease |
4.9% |
Rheumatoid Arthritis |
3.7% |
Plasma Cell Myeloma |
3.6% |
Hypertension |
3.4% |
Pain |
3.4% |
Supplementation Therapy |
2.1% |
Depression |
2.0% |
Vitamin Supplementation |
2.0% |
Prophylaxis |
1.6% |
Gastrooesophageal Reflux Disease |
1.3% |
Diabetes Mellitus |
1.3% |
Anxiety |
1.3% |
Nausea |
1.2% |
Atrial Fibrillation |
1.2% |
Colitis Ulcerative |
1.1% |
Hepatitis C |
1.1% |
Inflammatory Bowel Disease |
1.1% |
Psoriasis |
1.1% |
|
Vomiting |
11.4% |
Weight Decreased |
10.0% |
Death |
8.4% |
Pulmonary Embolism |
6.3% |
Weight Increased |
5.1% |
White Blood Cell Count Decreased |
4.7% |
Pain |
4.6% |
Injection Site Pain |
4.3% |
Crohn's Disease |
4.1% |
Pneumonia |
4.1% |
Vision Blurred |
4.1% |
Plasma Cell Myeloma |
4.0% |
Nausea |
3.8% |
Tremor |
3.8% |
Visual Impairment |
3.8% |
Drug Ineffective |
3.6% |
Pyrexia |
3.6% |
Urinary Tract Infection |
3.6% |
Sinusitis |
3.5% |
Pruritus |
3.2% |
|